Prostate Disease

Prostate cancer charity launches day of action
THE Prostate Cancer Charity is urging people in Burnham and Highbridge to make sure victims of the disease are getting the support they are entitled to.

MDCH, Prostate Cancer Research Fund receives $52,000 matching grant from Michigan Blues Foundation
LANSING — The Prostate Cancer Research Fund has received a $52,000 grant from the Blue Cross Blue Shield of Michigan Foundation to help in the fight against the most frequently diagnosed cancer in Michigan, and the second leading cause of cancer-related deaths for men. read more

Prostate Cancer Treatment Expert Dr. David B. Samadi, MD Responds To Cancer Institute Of New Jersey Study
According to a new study, who you see for prostate cancer heavily determines the treatment you will receive. The study, released by The Cancer Institute of New Jersey in New Brunswick and published in the Archives of Internal Medicine, claims that while most prostate cancer treatment options differ in many aspects, the majority of options are similar across the board. It suggested that the ...

Study shows further benefits of noscapine for prostate cancer
New research has revealed a major breakthrough in the use of cough medicine ingredient noscapine as a prophylactic treatment for prostate cancer.

Study shows further benefits of noscapine for prostate cancer
( MedInsight Research Institute ) Noscapine, a non-addictive derivative of opium, has previously been shown to have anti-cancer properties. This is the first study examining noscapine's potential as a prophylactic agent against prostate cancer.

Sanofi Drug Shows Promise Against Prostate Cancer
For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.

Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
UroToday.com - In this study, we reported our experience with sacral insufficiency fractures (IF) in patients with prostate cancer who underwent pelvic radiotherapy as part of their definitive treatment. Insufficiency fractures are considered a rare complication of radiotherapy. IF has been described after irradiation for gynaecologic, anal, and rectal cancer. Data in prostate cancer patients is ...

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are ...

Watchful waiting is viable option for many men with low risk prostate cancer
Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. James L. Mohler, MD, of Roswell Park Cancer Institute and chair of the NCCN Guidelines Panel for Prostate Cancer, discussed the role of active surveillance as well as other treatment options recommended in the ...

Screening and Detection of Breast Cancer and Prostate Cancer [Letters]
To the Editor: Dr Esserman and colleagues 1 provided lucid and compelling reasons to challenge the current methods of screening for prostate and breast cancers and correctly concluded that "tumor biology dictates and trumps stage, so the basic assumption . . . that finding and treating early stage disease will prevent late stage or metastatic disease may not always be correct."